Previous close | 1.5200 |
Open | 1.5300 |
Bid | 1.6500 x 600 |
Ask | 1.6800 x 400 |
Day's range | 1.5300 - 1.7000 |
52-week range | 0.6200 - 2.3100 |
Volume | |
Avg. volume | 1,786,078 |
Market cap | 208.005M |
Beta (5Y monthly) | 1.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
We can readily understand why investors are attracted to unprofitable companies. For example, although...
We feel now is a pretty good time to analyse Atossa Therapeutics, Inc.'s ( NASDAQ:ATOS ) business as it appears the...
Here is how Atossa Genetics Inc. (ATOS) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.